Finding New Echocardiographic Parameters for Reverse Cardiac Remodeling: Isovolumic Contraction Velocity in Heart Failure with Reduced Ejection Fraction and Effect of Sacubitril/Valsartan: the PROVE-HF Study

J Card Fail. 2024 May;30(5):666-668. doi: 10.1016/j.cardfail.2023.12.005. Epub 2023 Dec 29.

Authors

Estefania Oliveros¹, Julia Grapsa²

Affiliations

¹ Lewis Katz School of Medicine, Temple University Hospital, Philadelphia, PA, USA. Electronic address: [email protected].
² Guy's and St Thomas' NHS Trust Hospitals, London, UK.

PMID: 38160996
DOI: 10.1016/j.cardfail.2023.12.005

No abstract available

Publication types

Editorial

MeSH terms

Aminobutyrates / pharmacology
Aminobutyrates / therapeutic use
Angiotensin Receptor Antagonists* / pharmacology
Angiotensin Receptor Antagonists* / therapeutic use
Biphenyl Compounds*
Drug Combinations
Echocardiography / methods
Heart Failure* / diagnostic imaging
Heart Failure* / drug therapy
Heart Failure* / physiopathology
Humans
Male
Myocardial Contraction / drug effects
Myocardial Contraction / physiology
Randomized Controlled Trials as Topic
Stroke Volume* / drug effects
Stroke Volume* / physiology
Tetrazoles* / therapeutic use
Treatment Outcome
Valsartan*
Ventricular Remodeling / drug effects
Ventricular Remodeling / physiology

Substances

Aminobutyrates
Angiotensin Receptor Antagonists
Biphenyl Compounds
Drug Combinations
sacubitril and valsartan sodium hydrate drug combination
Tetrazoles
Valsartan